Macleods Pharma IPO

It is pharmaceutical company, engaged in developing, manufacturing, and marketing a wide range of formulations across several major therapeutic areas including antiinfectives, cardiovascular, anti-diabetic, dermatology, and hormone treatment.

Open Demat Account

Macleods Pharma IPO Details

Check out the issue details for Macleods Pharma IPO as disclosed in SEBI.

Price Band

Not Issued

Issue Size

Not Issued

Issue Type

Book Built

Open

Not Issued

Close

Not Issued

Macleods Pharma News

 IPO news not found.

Company Financials

You can get the following financial statements of Macleods Pharma as of now.

Company Name

Macleods Pharma

  Profit Loss
  Balance Sheet
  Quarterly
  Shareholding
  Cash Flow

Macleods Pharmaceuticals IPO Valuation

The approx valuation of Macleods Pharmaceuticals IPO company based on its price band and DRHP (prospectus) is: 

Particulars Value
Upper Price Band Rs __
Existing Shares (Qty) 59.88 Cr
EPS (FY21) Rs 33.74
Industry PE 32.53x

 

Macleods Pharmaceuticals IPO Issue Size

Macleods Pharmaceuticals IPO issue size is not disclosed. 

Issue Amount
Fresh Issue 0 Cr
Offer For Sale (Qty) 6.04 Cr

 

Macleods Pharmaceuticals IPO Market Lot

An Individual can apply for a minimum 1 lot of _ shares and a maximum of 13 lots of _ shares. Find the details below:

Application Lot Shares Amount
 Minimum  1 _ Rs _
 Maximum 13 _ Rs _

 

Macleods Pharmaceuticals IPO share offer

The category-wise shares offered are as follows:

Category % Offered
Qualified Institutional Maximum 50%
Non-Institutional Minimum 15%
Retail Individual Minimum 35%

 

The dates for the IPO is not been disclosed. 

Profit & Loss (All Figures in Cr. Adjusted EPS in Rs.)

PARTICULARS Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Net Sales 7014.11 7462.67 7813.3 8373.18 8991.37
Total Expenditure 4670.54 5903.28 6381.99 6239.62 6745.19
Operating Profit 2343.56 1559.38 1431.31 2133.56 2246.18
Other Income 544.64 125.82 213.34 499.41 316.74
Interest 5.84 10.81 7.43 11.61 8.54
Depreciation 132.13 156.55 169.85 163.86 172.88
Exceptional Items 0 0 0 0 0
Profit Before Tax 2750.23 1517.84 1467.37 2457.5 2381.5
Provision for Tax 533.91 350.61 -8.02 411.29 105.13
Net Profit 2216.33 1167.23 1475.39 2046.21 2276.37
Adjusted EPS (Rs.) 3.7 1.95 2.46 3.15 3.51

Balance Sheet (All Figures are in Crores.)

Particulars Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Equity and Liabilities
Share Capital 19.96 59.88 59.88 64.87 64.87
Total Reserves 4226.69 5353.38 6840.29 8877.05 11157.09
Borrowings 0 0 0 0 0.04
Other N/C liabilities -356.33 -298.23 -542.95 -379.48 -618.76
Current liabilities 1428.64 1324.91 1537.23 4063.84 2731.17
Total Liabilities 5318.96 6439.94 7894.45 12626.28 13334.41
Assets
Net Block 1399.64 1473.42 1618.99 1627.62 1766.33
Capital WIP 252.75 334.34 189.93 287.44 526.71
Intangible WIP 0 0 0 0 0
Investments 16.93 234.76 438.53 1688.86 1676.06
Loans & Advances 123.88 89.94 89.96 97.23 101.86
Other N/C Assets 220.6 771.75 546.2 793.94 509.56
Current Assets 3305.17 3535.73 5010.85 8131.19 8753.89
Total Assets 5318.96 6439.94 7894.45 12626.28 13334.41
* Other Non-current Liabilities include Net deferred Liabilities

Share Holding Pattern

Promoter Pledging %

Date Promoter % Pledge %
Mar 2021 100 0
Mar 2020 100 0
* Figures given above are % of equity capital

Cash Flows (All Figures are in Crores.)

PARTICULARS Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Profit from operations 2750.23 1517.84 1467.37 2457.5 2381.5
Adjustment -343 113.05 98.35 -274.51 13.92
Changes in Assets & Liabilities -654.3 95.14 664.11 -651.53 -239.19
Tax Paid -477.54 -314.77 -228.77 -341.18 -398.48
Operating Cash Flow 1275.39 1411.25 2001.06 1190.28 1757.75
Investing Cash Flow -1330.74 -1400.17 -2067.06 -1269.13 -1845.74
Financing Cash Flow 30.46 -21.12 95.36 104.74 48.48
Net Cash Flow -24.89 -10.04 29.36 25.89 -39.51
X